NewYork-Presbyterian Hospital was among the backers in a round that took the healthcare planning platform’s total funding to more than $43m.
Month: May 2018
Oriola makes an appointment to fund Doktor.se
Oriola took a 17% stake in the corporate health services startup through through the round, having already been a strategic partner.
BP and Nio Capital mobilise strategic partnership
BP has signed a memorandum of understanding with Nio Capital that is expected to lead to investments in advanced mobility technologies.
Ansun inhales $85m in series A round
Lilly Asia Ventures and Sinopharm Healthcare Fund co-led the round that will fund a phase 3 trial for Ansun Biopharma’s parainfluenza treatment.
Provention Bio pursues $50m IPO prize
Johnson & Johnson, Vactech and MacroGenics all own stakes in Provention they got through licensing drug candidates to the company.
Beam Therapeutics lasers in on $87m
Beam, a genetic medicine developer in which Editas Medicine is a shareholder, has emerged from stealth with an $87m series A round.
Corporates fuel third Renaissance fund
Renaissance Venture Capital Fund has closed its third fund of funds at $81m, securing several Michigan-based corporates as limited partners.
Carousell revolves around to $85m series C
Existing backer Rakuten Ventures co-led a series C round for the used goods e-commerce platform, bringing its total funding to $127m.
Unisound rings up $100m
China Electronics Corporation Data led the artificial intelligence chip developer’s latest round, which included Qihoo 360.
Dawn closes $232m fund with EIF support
The London-based VC investor has surprised observers by securing $74m from the EU-backed agency.
Entrepreneurial success and CVC: unravelling the paradox
I began my doctoral work in management after a long career as a new product development engineering executive and soon became struck by the lack of research into how entrepreneurs benefited from corporate venture capital investments. This lack of research insight exacerbated the concerns in the research literature that corporate investors are inhibited from making… Continue reading Entrepreneurial success and CVC: unravelling the paradox
Eight-year review
Andrew Gaule, CEO, Aimava, reviews eight years of interviews with leaders of innovation and corporate venturing.
Israel – 10 years on, what is the status of the ‘startup nation’?
Referring to Israel as the “startup nation” is hardly original now. Having first arisen in 2009 with the publication of Saul Singer’s and Dan Senor’s book Start-up Nation, the nickname has remained associated with the country – and not without good reason. In spite of having a population of just 8.5 million people, which places… Continue reading Israel – 10 years on, what is the status of the ‘startup nation’?
Continuing metamorphosis of the media sector
Sector focus: Media